The drug delivery devices market refers to the development, production, and sale of medical devices used to administer drugs to patients. These devices are designed to improve the safety, efficacy, and convenience of drug delivery, and include a wide range of products such as syringes, needles, inhalers, infusion pumps, and implantable devices.
Global Drug Delivery Devices Market Size was valued at USD 269 Billion in 2022, and it is expected to reach USD 421 billion by the end of 2030 with growth at a CAGR of 4.6% during the forecast period 2022-2030.
North American Drug Delivery Devices Market registering at highest revenue share over 35%.
By Route of Administration, By Application, By End User, and By Country
Largest Growing Market
Fastest Growing Market
Several Insights Covered
Market sizing, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Global, Regional and Country Level Analysis, Competitive Landscape, Investment Opportunities
Key Companies Profiled
Pfizer Inc., Novartis AG, F Hoffmann-La Roche Ltd, Johnson and Johnson, Bayer AG, Becton, Dickinson and Company, Altaris, Holozymes Inc. (Antares Pharma Inc.), GlaxoSmithKline PLC, and Teva Pharmaceutical Industries Ltd
The North American drug delivery devices market has been growing rapidly in recent years due to a number of factors, including the increasing prevalence of chronic diseases such as diabetes, cancer, and heart disease, the development of new and innovative drug delivery technologies, and the growing demand for convenient and non-invasive drug delivery methods.
One of the key trends in the drug delivery devices market in the North American region is the increasing adoption of wearable and implantable devices. These devices are designed to continuously monitor and deliver drugs to patients, providing a more personalized and effective treatment experience. For example, wearable insulin pumps are now available for people with diabetes, allowing them to manage their disease with greater ease and flexibility.
Despite the many benefits of drug delivery devices, there are also some challenges that need to be addressed. For example, many of these devices can be expensive and difficult to use, leading to low patient adherence. In addition, there are concerns about the safety and reliability of these devices, as well as the potential for cybersecurity threats.
Despite these challenges, the North American drug delivery devices market is expected to continue growing in the coming years, driven by advances in technology and the increasing demand for more effective and convenient drug delivery methods. Companies in the market are expected to continue investing in research and development to improve the safety and efficacy of their products and to bring new and innovative devices to market.
In conclusion, the drug delivery devices market is a rapidly growing industry, offering a wide range of products and technologies to meet the needs of patients and healthcare providers. As the demand for convenient and effective drug delivery methods continues to grow, the market is expected to continue expanding, driving innovation and improving patient outcomes.
By Route of Administration:
By End User:
Some of the Major Key Players profiled in the North America Drug Delivery Devices Market:
North America Drug Delivery Devices Market
1. Executive Summary
1.1 Introduction to North America Drug Delivery Devices Markets
1.2 North America Drug Delivery Devices Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in North America Drug Delivery Devices Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Drug Delivery Devices Market Trends in North America
3.2 North America Drug Delivery Devices Market Growth Drivers
3.3 North America Drug Delivery Devices Market Growth Restraints
4 North America Drug Delivery Devices Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. North America Drug Delivery Devices Market Segmentation- Outlook by Type
5.1 Drug Delivery Devices Market Share Analysis by Type, 2023
5.2 Injectable Drug Delivery Devices Market Size Outlook to 2030
5.3 Topical Drug Delivery Devices Market Size Outlook to 2030
5.4 Ocular Drug Delivery Devices Market Size Outlook to 2030
6. North America Drug Delivery Devices Market Segmentation- Outlook by Indication
6.1 North America Drug Delivery Devices Market Share Analysis by Indication, 2023
6.5 Infectious Diseases
7. North America Drug Delivery Devices Market Segmentation- Outlook by End-User
7.1 North America Drug Delivery Devices Market Share Analysis by End-User, 2023
7.2 Hospitals Market Outlook to 2030
7.3 Ambulatory Surgical Centers Market Outlook to 2030
8. North America Drug Delivery Devices Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 North America Drug Delivery Devices Market Outlook by Country, 2021 to 2030
8.3 United States Drug Delivery Devices Market Outlook, 2021 to 2030
8.4 Canada Drug Delivery Devices Market Outlook, 2021 to 2030
8.5 Mexico Drug Delivery Devices Market Outlook, 2021 to 2030
9. Profiles of major world Drug Delivery Devices Companies
9.1 Pfizer Inc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
9.2 Novartis AG
9.3 F Hoffmann-La Roche Ltd
9.4 Johnson and Johnson
9.5 Bayer AG
9.6 Becton, Dickinson, and Company
9.8 Holozymes Inc.
9.9 GlaxoSmithKline PLC
9.10 Teva Pharmaceutical Industries Ltd
10.1 Publisher’s Expertise
10.2 List of Tables and Charts
10.3 List of Exhibits
10.4 Legal Disclaimer
North America Drug Delivery Devices Market Forecasted from 2022-2030
The Drug Delivery Devices Market is projected to grow at a CAGR of 7.6% by 2030
Asia Pacific region is the highest CAGR in the global market, during 2022-2030
North America region contributing the largest share in the global market.
Some of the major players listed in the market report are, Pfizer Inc., Novartis AG, F Hoffmann-La Roche Ltd, Johnson and Johnson, Bayer AG, Becton, Dickinson and Company, Altaris, and More other players.